Abstract
With oral antiretroviral pre-exposure prophylaxis (PrEP) rollout expanding to include adolescents in South Africa, research is needed to better understand perceptions of PrEP acceptability among adolescents and clinical service providers. We conducted an exploratory mixed-methods study among 57 adolescents, 16–17 years of age, living with and without HIV, and 25 clinical service providers in Cape Town, South Africa from 2015 to 2016. Cross-sectional survey and semi-structured qualitative interview data were used to explore (1) willingness to use PrEP and support partner PrEP use among adolescents living with and without HIV, (2) willingness to prescribe or support prescription of PrEP among service providers, and (3) perceptions of barriers and facilitators to PrEP implementation and interpretations of PrEP efficacy messaging for adolescent HIV prevention among all participants. Acceptability of PrEP among participants was high. Support for PrEP uptake was linked to messages that positively framed PrEP’s protection potential (i.e., success- versus failure-framed messaging) among both adolescents and providers. Adolescents living without HIV endorsed high willingness to use PrEP and adolescents living with HIV endorsed high support for partner PrEP use. However, both groups noted that potential side effects, stigma, and PrEP’s partial efficacy may hinder uptake. Clinical service providers endorsed PrEP for sexually active adolescents and shared stigma and efficacy concerns. Further, service providers expressed desire for adolescent-tailored training and integration of PrEP delivery into primary care and family planning services. Efforts to educate adolescents and service providers about PrEP should consider how message framing may influence acceptability. Community PrEP education and adolescent-friendly delivery should be prioritized to alleviate predicted PrEP stigma and facilitate uptake.
Similar content being viewed by others
References
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.
Celum, C. L., Delany-Moretlwe, S., McConnell, M., Van Rooyen, H., Bekker, L. G., Kurth, A., et al. (2015). Rethinking HIV prevention to prepare for oral PrEP implementation for young African women. Journal of the International AIDS Society, 18, 20227.
Clement, M. E., Kofron, R., & Landovitz, R. J. (2020). Long-acting injectable cabotegravir for the prevention of HIV infection. Current Opinion in HIV and AIDS, 15(1), 19–26.
De Walque, D. (2007). Sero-discordant couples in five African countries: Implications for prevention strategies. Population and Development Review, 33(3), 501–523.
Dir, A. L., Coskunpinar, A., & Cyders, M. A. (2014). A meta-analytic review of the relationship between adolescent risky sexual behavior and impulsivity across gender, age, and race. Clinical Psychology Review, 34(7), 551–562.
Eaton, L. A., Kalichman, S. C., Price, D., Finneran, S., Allen, A., & Maksut, J. (2017). Stigma and conspiracy beliefs related to pre-exposure prophylaxis (PrEP) and interest in using PrEP among black and white men and transgender women who have sex with men. AIDS and Behavior, 21(5), 1236–1246.
Eyawo, O., de Walque, D., Ford, N., Gakii, G., Lester, R. T., & Mills, E. J. (2010). HIV status in discordant couples in sub-Saharan Africa: A systematic review and meta-analysis. The Lancet Infectious Diseases, 10(11), 770–777.
Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O'Reilly, K. R., Koechlin, F. M., et al. (2016). Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS, 30, 1973–1983.
Gill, K., Johnson, L., Dietrich, J., Myer, L., Marcus, R., Wallace, M., et al. (2020). Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: An open-label single-arm phase 2 trial. The Lancet Child & Adolescent Health, 4(12), 875–883.
Giovenco, D., Gill, K., Fynn, L., Duyver, M., O’Rourke, S., van der Straten, A., et al. (2021). Experiences of oral pre-exposure prophylaxis (PrEP) use disclosure among South African adolescent girls and young women and its perceived impact on adherence. PLoS ONE, 16(3), e0248307.
Giovenco, D., Kuo, C., Underhill, K., Hoare, J., & Operario, D. (2018). “The time has arrived”: Perceptions of behavioral adjustments in the context of pre-exposure prophylaxis availability among adolescents in South Africa. AIDS Education and Prevention, 30(6), 463–473.
Golub, S. A. (2018). PrEP stigma: Implicit and explicit drivers of disparity. Current HIV/AIDS Reports, 15(2), 190–197.
Grotevant, H. D., & Cooper, C. R. (1985). Patterns of interaction in family relationships and the development of identity exploration in adolescence. Child Development, 56, 415–428.
Haire, B. G. (2015). Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence—A narrative review. HIV/AIDS, 7, 241–249.
Hosek, S., Celum, C., Wilson, C. M., Kapogiannis, B., Delany-Moretlwe, S., & Bekker, L. G. (2016). Preventing HIV among adolescents with oral PrEP: Observations and challenges in the United States and South Africa. Journal of the International AIDS Society, 19, 21107.
Hosek, S. G., Landovitz, R. J., Kapogiannis, B., Siberry, G. K., Rudy, B., Rutledge, B., et al. (2017). Safety and feasibility of antiretroviral preexposure prophylaxis for adolescent men who have sex with men aged 15 to 17 years in the United States. JAMA Pediatrics, 171(11), 1063–1071.
Koechlin, F. M., Fonner, V. A., Dalglish, S. L., O’Reilly, K. R., Baggaley, R., Grant, R. M., et al. (2017). Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: A systematic review of the literature. AIDS and Behavior, 21(5), 1325–1335.
O’Malley, G., Barnabee, G., & Mugwanya, K. (2019). Scaling-up PrEP delivery in sub-Saharan Africa: What can we learn from the scale-up of ART? Current HIV/AIDS Reports, 16(2), 141–150.
Patton, G. C., Sawyer, S. M., Santelli, J. S., Ross, D. A., Afifi, R., Allen, N. B., et al. (2016). Our future: A Lancet commission on adolescent health and wellbeing. The Lancet, 387(10036), 2423–2478.
Peng, P., Su, S., Fairley, C. K., Chu, M., Jiang, S., Zhuang, X., & Zhang, L. (2018). A global estimate of the acceptability of pre-exposure prophylaxis for HIV among men who have sex with men: A systematic review and meta-analysis. AIDS and Behavior, 22(4), 1063–1074.
Shisana, O., Rehle, T., Simbayi, L. C., Zuma, K., Jooste, S., Zungu, N., et al. (2014). South African National HIV Prevalence, Incidence and Behaviour Survey, 2012. Retrieved from https://repository.hsrc.ac.za/bitstream/handle/20.500.11910/2490/8162.pdf?sequence=1&is
Steinberg, L. (2008). A social neuroscience perspective on adolescent risk taking. Developmental Review, 28(1), 78–106.
UNAIDS. (2016). AIDS by the numbers [Internet]. Available from: https://www.unaids.org/sites/default/files/media_asset/AIDS-by-the-numbers-2016_en.pdf.
Underhill, K., Morrow, K. M., Colleran, C., Calabrese, S. K., Operario, D., Salovey, P., & Mayer, K. H. (2016). Explaining the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention: A qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS and Behavior, 20(7), 1514–1526.
van der Straten, A., Stadler, J., Luecke, E., Laborde, N., Hartmann, M., Montgomery, E. T., & VOICE-C Study Team. (2014). Perspectives on use of oral and vaginal antiretrovirals for HIV prevention: The VOICE-C qualitative study in Johannesburg, South Africa. Journal of the International AIDS Society, 17, 19146.
Velloza, J., Khoza, N., Scorgie, F., Chitukuta, M., Mutero, P., et al. (2020). The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: A qualitative study. Journal of the International AIDS Society, 23(3), e25463.
Viner, R. M., Ozer, E. M., Denny, S., Marmot, M., Resnick, M., Fatusi, A., & Currie, C. (2012). Adolescence and the social determinants of health. The Lancet, 379(9826), 1641–1652.
Acknowledgements
This research was supported by NIH Grants R21AI116309, F31MH119965, and K01MH096646.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethics Statement
All study procedures were approved by ethical review committees at Brown University (Protocol #1207000666) and University of Cape Town (Protocol #HREC 072/2013) and were conducted in accordance with the 1964 Helsinki Declaration.
Informed consent
Informed assent and parental or caregiver consent was obtained for all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Giovenco, D., Kuo, C., Underhill, K. et al. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting. Arch Sex Behav 50, 2921–2931 (2021). https://doi.org/10.1007/s10508-021-02052-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-021-02052-2